glp 1 and cancer GLP-1 receptor agonists show anti-cancer benefits beyond weight loss New project announcement: HHS‑OIG Quantity:Subscribe: 180 Days Supply mb-1

glp 1 and cancer GLP-1 receptor agonists show anti-cancer benefits beyond weight loss New project announcement: HHS‑OIG Quantity:Subscribe: 180 Days Supply mb-1

New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our

GLP-1 medications provide important safety information on their websites, including possible side effects from taking the drug

mb-1

Quantity:Subscribe: 180 Days Supply

Clinical trials for tirzepatide have documented a range of side effects, including nausea, diarrhea, and fatigue